Your browser doesn't support javascript.
loading
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia.
Wang, Yu-Hung; Lin, Chien-Chin; Gurashi, Kristian; Yao, Chi-Yuan; Jerez, Andres; Hou, Hsin-An; Chou, Wen-Chien; Tien, Hwei-Fang; Batta, Kiran; Wiseman, Daniel H.
Affiliation
  • Wang YH; Division of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester, Manchester, UK.
  • Lin CC; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.
  • Gurashi K; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.
  • Yao CY; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Jerez A; Division of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester, Manchester, UK.
  • Hou HA; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.
  • Chou WC; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Tien HF; Haematology Department, Hospital Morales Meseguer, Murcia, Spain.
  • Batta K; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.
  • Wiseman DH; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.
Blood Cancer J ; 14(1): 112, 2024 Jul 12.
Article in En | MEDLINE | ID: mdl-38997261
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelomonocytic, Chronic / Tumor Suppressor Protein p53 Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Cancer J Year: 2024 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelomonocytic, Chronic / Tumor Suppressor Protein p53 Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Cancer J Year: 2024 Document type: Article Country of publication: United States